John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 4,730 shares at $10.83 ($52K) on 2022-09-06, disclosed to the SEC on 2022-09-08.
Scheduled sale ($52k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.83 | 2,379 | $26K | 49.9% |
| 2 | $10.99 | 2,351 | $26K | 50.1% |
| Total | $10.91 avg | 4,730 | $52K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |